Még nem keres résztvevőt itt: Egyesült ÁllamokFázis nélkül
Validate the Temporal Stability and Responsiveness of AI-COA® for Depression and Anxiety
A legfontosabb adatok
- Ki végzi
- Deliberate Solutions Inc.
- Hol
- Houston (Egyesült Államok)A helyszín megnézése
- Azonosító
- Állapot
- Toborzás még nem indult
- Résztvevők
- 150 fő, tervezett
- Kezdés
- 2026. márc. 1.
- Várható befejezés
- 2027. febr. 28.
- A vizsgálat típusa
- Megfigyeléses
- A regiszteradat frissítve
- 2025. december 12.
Ki vehet részt
- Életkor
- 18 év – 65 év
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 16 feltétel megnézéseKevesebb
Ki vehet részt
- English fluency
- 18 to 65 years of age
- HAM-D 17 > 10
- Starting, or has started, a new treatment for depression or anxiety within 2-3 weeks of enrollment
- Access to a laptop or other computer with a well functioning microphone and webcam, and a stable Internet connection
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Resides in the United States at the time of consent and during completion of study
Ki nem vehet részt
- Concurrent medication/treatment:; Receiving any fast-acting treatment for depression or anxiety (e.g. ketamine, psychedelics, deep brain stimulation, etc.) in between initial baseline assessment (A1) and Restest (A2) , or in between Follow up assessment (B1) and Retest (B2); Anxiolytics: Use of benzodiazepines or other anxiety-reducing medications that could affect speech or motor activity, within the past 4 weeks; Antipsychotics and Mood Stabilizers: Medications that can alter cognitive and motor functions, within the past 6 weeks; Stimulants: Use of medications like methylphenidate or amphetamines that affect energy levels and behavior, within the past 2 weeks; Epilepsy medication: seizure activity or medication side effects that may alter behavior, within the past 4 weeks
- Participants who have previously participated in another research project by Deliberate
- Any cognitive impairment that limits ability to provide informed consent or authorization
- Impairment that would prevent participants from completing an online survey and/or engaging in clinician assessment interviews (e.g., visual impairment, motor impairment, hearing impairment)
- Any history or evidence of any of the following conditions:; Neurodevelopmental, Neurocognitive, Neurodegenerative or movement disorders including, but not limited to:; Tourette's syndrome; Multiple Sclerosis; Amyotrophic Lateral Sclerosis; Parkinson's Disease; Stroke; Traumatic Brain Injury; Facial paralysis
- Conditions with vocal cord impact:; Vocal cord injury or cerebrovascular accident or head trauma with residual dysarthria in the past year; Disorders that may impact vocal cords such as acute or chronic laryngitis, vocal cord paresis or paralysis, or spasmodic dysphonia; Past or active heavy smokers (an average of >20 cigarettes per day)
- Schizophrenia Spectrum and Other Psychotic Disorders:; Individuals with a current or past diagnosis of Schizophrenia, Schizoaffective Disorder, or other psychotic disorders, including Delusional Disorder and Brief Psychotic Disorder; Current hypomanic episode as defined by DSM-5 criteria. This includes those with Bipolar I Disorder, Bipolar II Disorder, or Cyclothymic Disorder who are not in a stable mood state at the time of assessment; Chronic Pain Conditions: Such as fibromyalgia, which may affect facial expressions and vocal tone; Prosthetic Facial Devices: Could affect facial recognition algorithms. Cosmetic Procedures: Such as Botox injections or facelifts that can impact facial expressions; Dental Work: Major procedures that might affect speech
- Vulnerable or protected populations (e.g. prisoners)
- Acute intoxication at the time of the assessments
A fő feltételek kérdésként
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 18 és 65 év között vagy?
Helyszínek itt: Egyesült Államok
- Baylor College of MedicineHouston, Egyesült ÁllamokContact: Eric Storch, PhDToborzás még nem indult
A vizsgálatról
Mit akar kideríteni a vizsgálat
This study evaluates the reliability and responsiveness of the AI-COA®, a digital tool designed to assess the severity of depression and anxiety. The study compares the tool's performance against standard clinician ratings over 12 weeks to determine its consistency and sensitivity to symptom changes.
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Symptom Evaluation and Quantification for Unified Outcomes and Individualized Assessment
- Kérdések a feltételekről
- Forrás: NCT07279025: ki vehet részt
- A regiszteradat frissítve
- 2025. december 12.